Original Article | Published:

Adipose tissue mitochondrial capacity associates with long-term weight loss success

International Journal of Obesity volume 42, pages 817825 (2018) | Download Citation

Abstract

Objectives:

We investigated whether (1) subcutaneous adipose tissue (SAT) mitochondrial capacity predicts weight loss success and (2) weight loss ameliorates obesity-related SAT mitochondrial abnormalities.

Methods:

SAT biopsies were obtained from 19 clinically healthy obese subjects (body mass index (BMI) 34.6±2.7 kg m2) during a weight loss intervention (0, 5 and 12 months) and from 19 lean reference subjects (BMI 22.7±1.1 kg m–2) at baseline. Based on 1-year weight loss outcome, the subjects were divided into two groups: continuous weight losers (WL, n=6) and weight regainers (WR, n=13). Main outcome measures included SAT mitochondrial pathways from transcriptomics, mitochondrial amount (mitochondrial DNA (mtDNA), Porin protein levels), mtDNA-encoded transcripts, oxidative phosphorylation (OXPHOS) proteins, and plasma metabolites of the mitochondrial branched-chain amino-acid catabolism (BCAA) pathway. SAT and visceral adipose tissue (VAT) glucose uptake was measured with positron emission tomography.

Results:

Despite similar baseline clinical characteristics, SAT in the WL group exhibited higher gene expression level of nuclear-encoded mitochondrial pathways (P=0.0224 OXPHOS, P=0.0086 tricarboxylic acid cycle, P=0.0074 fatty acid beta-oxidation and P=0.0122 BCAA), mtDNA transcript COX1 (P=0.0229) and protein level of Porin (P=0.0462) than the WR group. Many baseline mitochondrial parameters correlated with WL success, and with SAT and VAT glucose uptake. During WL, the nuclear-encoded mitochondrial pathways were downregulated, together with increased plasma metabolite levels of BCAAs in both groups. MtDNA copy number increased in the WR group at 5 months (P=0.012), but decreased to baseline level between 5 and 12 months (P=0.015). The only significant change in the WL group for mtDNA was a reduction between 5 and 12 months (P=0.004). The levels of Porin did not change in either group upon WL.

Conclusions:

Higher mitochondrial capacity in SAT predicts good long-term WL success. WL does not ameliorate SAT mitochondrial downregulation and based on pathway expression, may paradoxically further reduce it.

Data availability:

The transcriptomics data generated in this study have been deposited to the Gene Expression Omnibus public repository, accession number GSE103769.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , , , et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008; 5: e51.

  2. 2.

    , , , , , et al. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes 2015; 64: 3135.

  3. 3.

    . The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008; 94: 206–218.

  4. 4.

    , , , . Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367–377.

  5. 5.

    . Effect of degree of weight loss on health benefits. Obes Res 1995; 3 (Suppl 2): 211s–216.

  6. 6.

    , , , , , et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 2016; 23: 591–601.

  7. 7.

    , . Weight loss diet studies: we need help not hype. The Lancet 2016; 388: 849–851.

  8. 8.

    , , , . Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol 2011; 301: R581–R600.

  9. 9.

    , . Adaptive reduction in basal metabolic rate in response to food deprivation in humans: a role for feedback signals from fat stores. Am J Clin Nutr 1998; 68: 599–606.

  10. 10.

    , , , , , et al. Macrophages and adipocytes in human obesity. Diabetes 2009; 58: 1558–1567.

  11. 11.

    , , , , , et al. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 2005; 81: 1275–1285.

  12. 12.

    , , , , , et al. Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. Am J Clin Nutr 2012; 96: 196–207.

  13. 13.

    , , , , , et al. A distinct adipose tissue gene expression response to caloric restriction predicts 6-mo weight maintenance in obese subjects. Am J Clin Nutr 2011; 94: 1399–1409.

  14. 14.

    , , , , , . Weight loss-induced changes in adipose tissue proteins associated with fatty acid and glucose metabolism correlate with adaptations in energy expenditure. Nutr Metab (Lond) 2015; 12: 1–8.

  15. 15.

    , , , , , et al. Diet-induced weight loss decreases adipose tissue oxygen tension with parallel changes in adipose tissue phenotype and insulin sensitivity in overweight humans. Int J Obes 2017; 41: 722–728.

  16. 16.

    , , , , , et al. Adipose tissue gene expression is differentially regulated with different rates of weight loss in overweight and obese humans. Int J Obes 2017; 41: 309–316.

  17. 17.

    , , , , , et al. Adipose tissue transcriptome reflects variations between subjects with continued weight loss and subjects regaining weight 6 mo after caloric restriction independent of energy intake. Am J Clin Nutr 2010; 92: 975–984.

  18. 18.

    , , , , , . Agreement of bioelectrical impedance with dual-energy X-ray absorptiometry and MRI to estimate changes in body fat, skeletal muscle and visceral fat during a 12-month weight loss intervention. Br J Nutr 2013; 109: 1910–1916.

  19. 19.

    , , , , , et al. Weight loss is associated with increased NAD+/SIRT1 expression but reduced PARP activity in white adipose tissue. J Clin Endocrinol Metab 2016; 101: 1263–1273.

  20. 20.

    , , , , , et al. Subcutaneous adipose tissue gene expression and DNA methylation respond to both short- and long-term weight loss. Int J Obes 2017 doi:10.1038/ijo.2017.245.

  21. 21.

    , , , , , . Evolving concepts on adjusting human resting energy expenditure measurements for body size. Obes Rev 2012; 13: 1001–1014.

  22. 22.

    , , , , . qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8: R19–R19.

  23. 23.

    , , , , , et al. Mitochondrial DNA replication defects disturb cellular dNTP pools and remodel one-carbon metabolism. Cell Metab 2016; 23: 635–648.

  24. 24.

    , . Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 2014; 10: 723–736.

  25. 25.

    , , , , , et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311–326.

  26. 26.

    , , . A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936–942.

  27. 27.

    , , , . Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 2005; 54: 1392–1399.

  28. 28.

    , , , , , et al. Mitochondrial bioenergetics is not impaired in nonobese subjects with type 2 diabetes mellitus. Metabolism 2011; 60: 1702–1710.

  29. 29.

    , , , , , et al. Obesity affects mitochondrial citrate synthase in human omental adipose tissue. ISRN Obes 2013; 2013: 826027.

  30. 30.

    , , , , , et al. Inverse relationship between body mass index and mitochondrial oxidative phosphorylation capacity in human subcutaneous adipocytes. Am J Physiol Endocrinol Metab 2015; 309: E380–E387.

  31. 31.

    , , , , , et al. Important mitochondrial proteins in human omental adipose tissue show reduced expression in obesity. J Proteomics 2015; 124: 79–87.

  32. 32.

    , , , , , et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia 2014; 57: 167–176.

  33. 33.

    , , , , , . Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab 2014; 99: E209–E216.

  34. 34.

    , , , , , et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 2008; 9: R14.

  35. 35.

    , . Long-term weight loss maintenance. Am J Clin Nutr 2005; 82: 222S–225SS.

  36. 36.

    , , , . Does dieting make you fat[quest] a twin study. Int J Obes 2012; 36: 456–464.

  37. 37.

    , , , , , et al. Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue. Sci Rep 2015; 5: 14841.

  38. 38.

    , , , , , et al. Adipose tissue mitochondrial respiration and lipolysis before and after a weight loss by diet and RYGB. Obesity 2015; 23: 2022–2029.

  39. 39.

    , , , , , et al. Roux-en-Y gastric bypass acutely decreases protein carbonylation and increases expression of mitochondrial biogenesis genes in subcutaneous adipose tissue. Obes Surg 2015; 25: 2376–2385.

  40. 40.

    , , , , , et al. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care 2014; 37: 3150–3156.

  41. 41.

    , , , , , et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 2011; 3: 80re2.

Download references

Acknowledgements

We thank the study participants for their contribution to this research. We thank Professor Jaakko Kaprio for contributions in collecting the study participants. We acknowledge Laura Suojanen (MSc) for managing the WL intervention, Sari Räsänen (MSc) for analyzing the food diary data, Juha Rantanen, Mia Urjansson and Antti Muranen (MSc) for their technical expertise in the laboratory, and Biomedicum Functional Genomics Unit (FuGU) for their services. The study was supported by grants from the Academy of Finland (grant numbers 272376, 266286, 285963 and 265240), the Novo Nordisk Foundation, Finnish Diabetes Research Foundation, Gyllenberg Foundation, Jalmari and Rauha Ahokas Foundation, Finnish Foundation for Cardiovascular Research, Sigrid Jusélius Foundation, Biocentrum Helsinki, University of Helsinki, Maud Kuistila Foundation, Biomedicum Helsinki Foundation, Paulo Foundation, Finnish Medical Foundation and Emil Aaltonen Foundation, the donation from Paavo and Eila Salonen to Central Finland Hospital District of Central Finland, Turku University Hospital Research Funds and Helsinki University Hospital Research Funds.

Author contributions

RJ performed experiments, analyzed and collected the data, and wrote the manuscript. RR-T and ER performed experiments and analyzed data. KHP, SK and SH collected the material and data. LS performed the whole-genome transcriptomics analyses. RJ, MM and SJ analyzed data. AP and VV performed the metabolite analysis. KAV measured and analyzed the PET data. EP designed and supervised laboratory analyses. KHP, KAV and AR designed the study. KHP supervised the study and analyzed data. All authors participated in the writing and revision of the manuscript.

Author information

Affiliations

  1. Obesity Research Unit, Research Programs Unit, Diabetes and Obesity, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

    • R Jokinen
    • , S Kaye
    • , S Heinonen
    • , M Myöhänen
    • , E Rappou
    • , S Jukarainen
    • , A Rissanen
    •  & K H Pietiläinen
  2. Research Programs Unit, Molecular Neurology, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

    • R Rinnankoski-Tuikka
    •  & E Pirinen
  3. Research Programs Unit, Genome-Scale Biology, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

    • L Saarinen
  4. Department of Psychiatry, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland

    • A Rissanen
  5. Metabolomics Unit, Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland

    • A Pessia
    •  & V Velagapudi
  6. Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland

    • K A Virtanen
  7. Endocrinology, Abdominal Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland

    • K H Pietiläinen

Authors

  1. Search for R Jokinen in:

  2. Search for R Rinnankoski-Tuikka in:

  3. Search for S Kaye in:

  4. Search for L Saarinen in:

  5. Search for S Heinonen in:

  6. Search for M Myöhänen in:

  7. Search for E Rappou in:

  8. Search for S Jukarainen in:

  9. Search for A Rissanen in:

  10. Search for A Pessia in:

  11. Search for V Velagapudi in:

  12. Search for K A Virtanen in:

  13. Search for E Pirinen in:

  14. Search for K H Pietiläinen in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to K H Pietiläinen.

Supplementary information

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/ijo.2017.299

Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)

Further reading